These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 10731633

  • 1. Kinetic analysis of LY320236: competitive inhibitor of type I and non-competitive inhibitor of type II human steroid 5alpha-reductase.
    McNulty AM, Audia JE, Bemis KG, Goode RL, Rocco VP, Neubauer BL.
    J Steroid Biochem Mol Biol; 2000; 72(1-2):13-21. PubMed ID: 10731633
    [Abstract] [Full Text] [Related]

  • 2. Comparative study of human steroid 5alpha-reductase isoforms in prostate and female breast skin tissues: sensitivity to inhibition by finasteride and epristeride.
    Ranjan M, Diffley P, Stephen G, Price D, Walton TJ, Newton RP.
    Life Sci; 2002 May 31; 71(2):115-26. PubMed ID: 12031682
    [Abstract] [Full Text] [Related]

  • 3. Characterization of type I 5 alpha-reductase activity in DU145 human prostatic adenocarcinoma cells.
    Kaefer M, Audia JE, Bruchovsky N, Goode RL, Hsiao KC, Leibovitch IY, Krushinski JH, Lee C, Steidle CP, Sutkowski DM, Neubauer BL.
    J Steroid Biochem Mol Biol; 1996 May 31; 58(2):195-205. PubMed ID: 8809201
    [Abstract] [Full Text] [Related]

  • 4. Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1.
    Issa S, Schnabel D, Feix M, Wolf L, Schaefer HE, Russell DW, Schweikert HU.
    J Clin Endocrinol Metab; 2002 Dec 31; 87(12):5401-7. PubMed ID: 12466325
    [Abstract] [Full Text] [Related]

  • 5. Effect of a novel steroid (PM-9) on the inhibition of 5alpha-reductase present in Penicillium crustosum broths.
    Flores E, Cabeza M, Quiroz A, Bratoeff E, García G, Ramírez E.
    Steroids; 2003 Mar 31; 68(3):271-5. PubMed ID: 12628690
    [Abstract] [Full Text] [Related]

  • 6. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G, Rittmaster RS, Klocker H.
    Eur Urol; 2000 Apr 31; 37(4):367-80. PubMed ID: 10765065
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibitory effects of Serenoa repens on the kinetic of pig prostatic microsomal 5alpha-reductase activity.
    Palin MF, Faguy M, LeHoux JG, Pelletier G.
    Endocrine; 1998 Aug 31; 9(1):65-9. PubMed ID: 9798732
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5alpha-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat.
    Stuart JD, Lee FW, Simpson Noel D, Kadwell SH, Overton LK, Hoffman CR, Kost TA, Tippin TK, Yeager RL, Batchelor KW, Bramson HN.
    Biochem Pharmacol; 2001 Oct 01; 62(7):933-42. PubMed ID: 11543729
    [Abstract] [Full Text] [Related]

  • 11. Phase I and clinical pharmacology of a type I and II, 5-alpha-reductase inhibitor (LY320236) in prostate cancer: elevation of estradiol as possible mechanism of action.
    Eisenberger MA, Laufer M, Vogelzang NJ, Sartor O, Thornton D, Neubauer BL, Sinibaldi V, Lieskovsky G, Carducci MA, Zahurak M, Raghavan D.
    Urology; 2004 Jan 01; 63(1):114-9. PubMed ID: 14751361
    [Abstract] [Full Text] [Related]

  • 12. 5alpha-reductase activity in the prostate.
    Steers WD.
    Urology; 2001 Dec 01; 58(6 Suppl 1):17-24; discussion 24. PubMed ID: 11750244
    [Abstract] [Full Text] [Related]

  • 13. The effects of progesterone, 4,16-androstadien-3-one and MK-434 on the kinetics of pig testis microsomal testosterone-4-ene-5alpha-reductase activity.
    Cooke GM, Pothier F, Murphy BD.
    J Steroid Biochem Mol Biol; 1997 Mar 01; 60(5-6):353-9. PubMed ID: 9219928
    [Abstract] [Full Text] [Related]

  • 14. Steroid 5alpha-reductase inhibitors.
    Flores E, Bratoeff E, Cabeza M, Ramirez E, Quiroz A, Heuze I.
    Mini Rev Med Chem; 2003 May 01; 3(3):225-37. PubMed ID: 12570838
    [Abstract] [Full Text] [Related]

  • 15. Identification and partial characterization of two steroid 5 alpha-reductase isozymes in the canine prostate.
    Span PN, Schalken JA, Sweep FG, Smals AG.
    Prostate; 1998 Feb 15; 34(3):222-30. PubMed ID: 9492851
    [Abstract] [Full Text] [Related]

  • 16. Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II.
    Makridakis NM, di Salle E, Reichardt JK.
    Pharmacogenetics; 2000 Jul 15; 10(5):407-13. PubMed ID: 10898110
    [Abstract] [Full Text] [Related]

  • 17. Discovery of a novel hybrid from finasteride and epristeride as 5α-reductase inhibitor.
    Yao Z, Xu Y, Zhang M, Jiang S, Nicklaus MC, Liao C.
    Bioorg Med Chem Lett; 2011 Jan 01; 21(1):475-8. PubMed ID: 21094046
    [Abstract] [Full Text] [Related]

  • 18. In vitro inhibition of androstenedione 5alpha-reduction by finasteride in epithelium and stroma of human benign prostatic hyperplasia.
    Weisser H, Krieg M.
    J Steroid Biochem Mol Biol; 1998 Oct 01; 67(1):49-55. PubMed ID: 9780029
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological and molecular evidence for the expression of the two steroid 5 alpha-reductase isozymes in normal and hyperplastic human prostatic cells in culture.
    Berthaut I, Mestayer C, Portois MC, Cussenot O, Mowszowicz I.
    Prostate; 1997 Aug 01; 32(3):155-63. PubMed ID: 9254894
    [Abstract] [Full Text] [Related]

  • 20. 4-Methyl-3-oxo-4-aza-5alpha-androst-1-ene-17beta-N-aryl-carboxamides: an approach to combined androgen blockade [5alpha-reductase inhibition with androgen receptor binding in vitro].
    Tolman RL, Sahoo SP, Bakshi RK, Gratale D, Patel G, Patel S, Toney J, Chang B, Harris GS.
    J Steroid Biochem Mol Biol; 1997 Mar 01; 60(5-6):303-9. PubMed ID: 9219921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.